# xDRIVE for Florida-based Cancer Patients

> **NCT07167381** · NA · RECRUITING · sponsor: **First Ascent Biomedical Inc.** · enrollment: 210 (estimated)

## Conditions studied

- Cancer
- Neoplams
- Refractory
- Recurrence
- Leukaemia
- Lymphoma
- Solid Tumor Malignancies
- Solid Cancers

## Interventions

- **DIAGNOSTIC_TEST:** xDRIVE Tumor Profiling

## Key facts

- **NCT ID:** NCT07167381
- **Lead sponsor:** First Ascent Biomedical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07167381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07167381, "xDRIVE for Florida-based Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07167381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*